The novel role of platelet-activating factor in protecting mice against lipopolysaccharide-induced endotoxic shock

PLoS ONE

Volumn 4, Issue 8, 2009, Pages

  Jeong, Young Il ^a   Jung, In Duk ^a   Lee, Chang Min ^a   Chang, Jeong Hyun ^c   Chun, Sung Hak ^a   Noh, Kyong Tae ^a   Jeong, Soo Kyung ^a   Shin, Yong Kyoo ^d   Lee, Won Suk ^b   Kang, Mi Sun ^b   Lee, Sang Yull ^b   Lee, Jae Dong ^a   Park, Yeong Min ^a  

^a Pusan National University   (South Korea)

^b Pusan National University School of Medicine   (South Korea)

^c Daegu Haany University   (South Korea)

^d Chung Ang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR ALPHA; AUTACOID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG EFFICACY; HYPOTENSION; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE; MORTALITY; MOUSE; MULTIPLE ORGAN FAILURE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIMARY PREVENTION; PROTECTION; SEPTIC SHOCK; SURVIVAL RATE; ANIMAL; DRUG EFFECT; METABOLISM;

MUS;

ANIMALS; APOPTOSIS; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; LYMPHOCYTES; MICE; PLATELET ACTIVATING FACTOR; SHOCK, SEPTIC;

EID: 68349154445     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0006503     Document Type: Article

References (25)

1. Angus DC, Linde-Zwirble WT, Clermont G, Griffin MF, Clark RH (2001) Epidemiology of neonatal respiratory failure in the United States: projections from California and New York. Am J Respir Crit Care Med 164: 1154-1160.
2. Cavaillon JM, Adib-Conquy M, Fitting C, Adrie C, Payen D (2003) Cytokine cascade in sepsis. Scand J Infect Dis 35: 535-544.
3. Dinarello CA (1997) Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock. Chest 112: 321S-329S.
4. Hotchkiss RS, Karl IE (2003) The pathophysiology and treatment of sepsis. N Engl J Med 348: 138-150.
5. Hotchkiss RS, Tinsley KW, Swanson PE, Chang KC, Cobb JP, et al. (1999) Prevention of lymphocyte cell death in sepsis improves survival in mice. Proc Natl Acad Sci U S A 96: 14541-14546.
6. Imaizumi TA, Stafforini DM, Yamada Y, McIntyre TM, Prescott SM, et al. (1995) Platelet-activating factor: a mediator for clinicians. J Intern Med 238: 5-20.
7. Prescott SM, Zimmerman GA, McIntyre TM (1990) Platelet-activating factor. J Biol Chem 265: 17381-17384.
8. Casals-Stenzel J (1987) Protective effect of WEB 2086, a novel antagonist of platelet activating factor, in endotoxin shock. Eur J Pharmacol 135: 117-122.
9. Giral M, Balsa D, Ferrando R, Merlos M, Garcia-Rafanell J, et al. (1996) Effects of UR-12633, a new antagonist of platelet-activating factor, in rodent models of endotoxic shock. Br J Pharmacol 118: 1223-1231.
10. Mathiak G, Szewczyk D, Abdullah F, Ovadia P, Rabinovici R (1997) Platelet-activating factor (PAF) in experimental and clinical sepsis. Shock 7: 391-404.
11. Walterscheid JP, Ullrich SE, Nghiem DX (2002) Platelet-activating factor, a molecular sensor for cellular damage, activates systemic immune suppression. J Exp Med 195: 171-179.
12. Tjoelker LW, Wilder C, Eberhardt C, Stafforini DM, Dietsch G, et al. (1995) Anti-inflammatory properties of a platelet-activating factor acetylhydrolase. Nature 374: 549-553.
13. Beishuizen A, Vermes I, Haanen C (1998) Endogenous mediators in sepsis and septic shock. Adv Clin Chem 33: 55-131.
14. Kubin M, Kamoun M, Trinchieri G (1994) Interleukin 12 synergizes with B7/ CD28 interaction in inducing efficient proliferation and cytokine production of human T cells. J Exp Med 180: 211-222.
15. Lopez-Bojorquez LN, Dehesa AZ, Reyes-Teran R (2004) Molecular mechanisms involved in the pathogenesis of septic shock. Arch Med Res 35: 465-479.
16. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, et al. (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101: 1644-1655.
17. Ayala A, Herdon CD, Lehman DL, Ayala CA, Chaudry IH (1996) Differential induction of apoptosis in lymphoid tissues during sepsis: variation in onset, frequency, and the nature of the mediators. Blood 87: 4261-4275.
18. Hotchkiss RS, Chang KC, Swanson PE, Tinsley KW, Hui JJ, et al. (2000) Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte. Nat Immunol 1: 496-501.
19. Ishii S, Tuwaki T, Nagase T, Maki K, Tashiro F, et al. (1998) Impaired anaphylactic responses with intact sensitivity to endotoxin in mice lacking a platelet-activating factor receptor. J Exp Med 187: 1779-1788.
20. Doughty L, Carcillo JA, Kaplan S, Janosky J (1998) The compensatory antiinflammatory cytokine interleukin 10 response in pediatric sepsis-induced multiple organ failure. Chest 113: 1625-1631.
21. Gerard C, Bruyns C, Marchant A, Abramowicz D, Vandenabeele P, et al. (1993) Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med 177: 547-550.
22. Howard M, Muchamuel T, Andrade S, Menon S (1993) Interleukin 10 protects mice from lethal endotoxemia. J Exp Med 177: 1205-1208.
23. Steinhauser ML, Hogaboam CM, Kunkel SL, Lukacs LW, Strieter RM, et al. (1999) IL-10 is a major mediator of sepsis-induced impairment in lung antibacterial host defense. J Immunol 162: 392-399.
24. Sawyer DW, Donowitz GR, Mandell (1989) Polymorphonuclear neutrophils: an effective antimicrobial force. Rev Infect Dis 11 Suppl 7: S1532-1544.
25. Inaba K, Inaba M, Romani N, Aya H, Deguchi M, et al. (1992) Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 176: 1693-1702.